Trials / Completed
CompletedNCT01850212
A Phase 4 Cross-Sectional Study of Bone Mineral Density in HIV-1 Infected Subjects
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 476 (actual)
- Sponsor
- Gilead Sciences · Industry
- Sex
- All
- Age
- 50 Years
- Healthy volunteers
- Not accepted
Summary
A Phase 4 study is to characterize the profile of low bone mineral density (BMD) in ≥ 50 year old male subjects and post-menopausal female subjects on any tenofovir disoproxil fumarate (TDF)-based regimen
Conditions
Timeline
- Start date
- 2013-02-01
- Primary completion
- 2014-10-01
- Completion
- 2014-10-01
- First posted
- 2013-05-09
- Last updated
- 2014-10-31
Locations
73 sites across 13 countries: Austria, Belgium, France, Germany, Ireland, Italy, Netherlands, Poland, Portugal, Spain, Sweden, Switzerland, United Kingdom
Source: ClinicalTrials.gov record NCT01850212. Inclusion in this directory is not an endorsement.